Search research articles
Contact Us
Filters
Showing results (71-80 of 120) with videos related to
Page
of 12
Sort By:
Targeted Oncology
|
September 2, 2024
Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment
Takuya Sho, Goki Suda, Masatsugu Ohara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
February 21, 2016
Prevalence and characteristics of naturally occurring sofosbuvir resistance-associated variants in patients with hepatitis C virus genotype 1b infection
Jun Ito, Goki Suda, Yoshiya Yamamoto, et al.
Carcinogenesis
|
September 21, 2017
Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma
Osamu Maehara, Goki Suda, Mitsuteru Natsuizaka, et al.
Journal of Gastroenterology
|
November 19, 2020
Tenofovir-disoproxil-fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection
Kazuharu Suzuki, Goki Suda, Yoshiya Yamamoto, et al.
Carcinogenesis
|
May 26, 2020
Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1-3 signaling, but not FGFR4 signaling
Taku Shigesawa, Osamu Maehara, Goki Suda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 20, 2017
Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study
Goki Suda, Jun Ito, Atsushi Nagasaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
February 7, 2022
The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease
Akihisa Nakamura, Koji Yamamoto, Rei Takeda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 12, 2014
Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions
Goki Suda, Yoshiya Yamamoto, Astushi Nagasaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 25, 2024
Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study
Zijian Yang, Goki Suda, Takuya Sho, et al.
Journal of Gastroenterology
|
January 16, 2016
Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C
Goki Suda, Mineo Kudo, Atsushi Nagasaka, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 120) with videos related to
Sort By:
Page
of 12
Targeted Oncology
|
September 2, 2024
Efficacy and Safety of Durvalumab/Tremelimumab in Unresectable Hepatocellular Carcinoma as Immune Checkpoint Inhibitor Rechallenge Following Atezolizumab/Bevacizumab Treatment
Takuya Sho, Goki Suda, Masatsugu Ohara, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
February 21, 2016
Prevalence and characteristics of naturally occurring sofosbuvir resistance-associated variants in patients with hepatitis C virus genotype 1b infection
Jun Ito, Goki Suda, Yoshiya Yamamoto, et al.
Carcinogenesis
|
September 21, 2017
Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma
Osamu Maehara, Goki Suda, Mitsuteru Natsuizaka, et al.
Journal of Gastroenterology
|
November 19, 2020
Tenofovir-disoproxil-fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection
Kazuharu Suzuki, Goki Suda, Yoshiya Yamamoto, et al.
Carcinogenesis
|
May 26, 2020
Lenvatinib suppresses cancer stem-like cells in HCC by inhibiting FGFR1-3 signaling, but not FGFR4 signaling
Taku Shigesawa, Osamu Maehara, Goki Suda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
July 20, 2017
Add-on effects of fluvastatin in simeprevir/pegylated-interferon/ribavirin combination therapy for patients with genotype 1 hepatitis C virus infection: A randomized controlled study
Goki Suda, Jun Ito, Atsushi Nagasaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
February 7, 2022
The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease
Akihisa Nakamura, Koji Yamamoto, Rei Takeda, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
September 12, 2014
Serum granulysin levels as a predictor of serious telaprevir-induced dermatological reactions
Goki Suda, Yoshiya Yamamoto, Astushi Nagasaka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
November 25, 2024
Association of proteinuria with improved prognosis in unresectable hepatocellular carcinoma treated with atezolizumab and bevacizumab, and the predictive role of serum vascular endothelial growth factor D levels: A multicenter retrospective study
Zijian Yang, Goki Suda, Takuya Sho, et al.
Journal of Gastroenterology
|
January 16, 2016
Efficacy and safety of daclatasvir and asunaprevir combination therapy in chronic hemodialysis patients with chronic hepatitis C
Goki Suda, Mineo Kudo, Atsushi Nagasaka, et al.
Page
of 12